PDF herunterladen
Fortschr Neurol Psychiatr 2006; 74(2): 71-76
DOI: 10.1055/s-2004-830295
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Erektile Dysfunktion bei Depressionen und antidepressiver Therapie - derzeitige Therapieoptionen

Erectile Dysfunction in Depression and under Treatment with Antidepressants - Current Treatment OptionsS.  Walther1, 2 , R.  Mahlberg1
  • 1Psychiatrische Universitätsklinik der Charité im St. Hedwig Krankenhaus, Charité Universitätsmedizin Berlin - Campus Mitte (Direktor: Prof. Dr. med. A. Heinz)
  • 2Universitäre Psychiatrische Dienste Bern, Direktion Sozial- und Gemeindepsychiatrie (Direktor: Prof. Dr. med. Dr. phil. H. D. Brenner)
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
20. Juni 2005 (online)

    Lizenzen und Reprints

Zusammenfassung

Die erektile Dysfunktion (ED) ist eine weitverbreitete und schambehaftete Störung. Sie kann als Symptom einer Depression oder als unerwünschte Wirkung antidepressiver Medikation auftreten. ED führt häufig zum Therapieabbruch insbesondere in der Rezidivprophylaxe. Mit den Phosphodiesterasehemmern wie Sildenafil, Tadalafil und Vardenafil können erektile Dysfunktionen multipler Genese erfolgreich behandelt werden. Durch den komplementären Einsatz in der Psychiatrie kann eine Verbesserung bei der Behandlung bestimmter Depressionsformen erzielt werden. Außerdem kann sich dadurch die Compliance medikamentöser antidepressiver Therapien erhöhen.

Abstract

Erectile dysfunction (ED) is a common problem in the general population, but also a symptom of both treated and untreated depression. As a side effect of antidepressant medication, erectile dysfunction appears to be one of the principal reasons for discontinuing antidepressant treatment. Avoiding or switching antidepressants is problematic, as this may lead to an increase in depressive symptoms. Our review shows that oral phosphodiesterase inhibitors are an option in treating both ED resulting from depression and from antidepressant medication.

Literatur

  • 1 Bauer M, Whybrow P C, Angst J. et al . World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.  World J Biol Psychiatry. 2002;  3 5-43
    CrossrefPubMedGoogle Scholar
  • 2 Nurnberg H G, Hensley P L. Sildenafil citrate for the management of antidepressant-associated erectile dysfunction.  J Clin Psychiatry. 2003;  64 (Suppl 10) 20-25
    Google Scholar
  • 3 NIH Consensus Conference . Impotence. NIH Consensus Development Panel on Impotence.  JAMA. 1993;  270 83-90
    CrossrefPubMedGoogle Scholar
  • 4 Derouet H, Osterhage J, Sittinger H. Erektile Funktionsstörungen - Epidemiologie, Physiologie, Ätiologie, Diagnostik und Therapie.  Nervenarzt. 2004;  75 595-605
    PubMedGoogle Scholar
  • 5 Fazio L, Brock G. Erectile dysfunction: management update.  CMAJ. 2004;  170 1429-1437
    CrossrefPubMedGoogle Scholar
  • 6 Mann K, Pankok J, Connemann B. et al . Sleep investigations in erectile dysfunction.  J Psychiatr Res. 2005;  39 93-99
    CrossrefPubMedGoogle Scholar
  • 7 Seidman S N. Exploring the relationship between depression and erectile dysfunction in aging men.  J Clin Psychiatry. 2002;  63 (Suppl 5) 5-12
    PubMedGoogle Scholar
  • 8 Araujo A B, Durante R, Feldman H A. et al . The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study.  Psychosom Med. 1998;  60 458-465
    PubMedGoogle Scholar
  • 9 Araujo A B, Johannes C B, Feldman H A. et al . Relation between psychosocial risk factors and incident erectile dysfunction: prospective results from the Massachusetts Male Aging Study.  Am J Epidemiol. 2000;  152 533-541
    Google Scholar
  • 10 Rosen R C, Marin H. Prevalence of antidepressant-associated erectile dysfunction.  J Clin Psychiatry. 2003;  64 (Suppl 10) 5-10
    CrossrefPubMedGoogle Scholar
  • 11 Braun M, Wassmer G, Klotz T. et al . Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’.  Int J Impot Res. 2000;  12 305-311
    Google Scholar
  • 12 Schäfer G A, Englert H S, Ahlers C J. et al . Erektionsstörung und Lebensqualität - Erste Ergebnisse der Berliner Männer-Studie.  Sexuologie. 2003;  10 50-60
    PubMedGoogle Scholar
  • 13 Nicolosi A, Moreira Jr E D, Shirai M. et al . Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction.  Urology. 2003;  61 201-206
    CrossrefPubMedGoogle Scholar
  • 14 Shabsigh R, Klein L T, Seidman S. et al . Increased incidence of depressive symptoms in men with erectile dysfunction.  Urology. 1998;  52 848-852
    CrossrefPubMedGoogle Scholar
  • 15 Steiger A, Holsboer F, Benkert O. Studies of nocturnal penile tumescence and sleep electroencephalogram in patients with major depression and in normal controls.  Acta Psychiatr Scand. 1993;  87 358-363
    PubMedGoogle Scholar
  • 16 Nicolosi A, Moreira Jr E D, Villa M. et al . A population study of the association between sexual function, sexual satisfaction and depressive symptoms in men.  J Affect Disord. 2004;  82 235-243
    CrossrefPubMedGoogle Scholar
  • 17 Kantor J, Bilker W B, Glasser D B. et al . Prevalence of erectile dysfunction and active depression: an analytic cross-sectional study of general medical patients.  Am J Epidemiol. 2002;  156 1035-1042
    CrossrefPubMedGoogle Scholar
  • 18 Souverein P C, Egberts A C, Sturkenboom M C. et al . The Dutch cohort of sildenafil users: baseline characteristics.  BJU Int. 2001;  87 648-653
    CrossrefPubMedGoogle Scholar
  • 19 Rosen R C, Lane R M, Menza M. Effects of SSRIs on sexual function: a critical review.  J Clin Psychopharmacol. 1999;  19 67-85
    CrossrefPubMedGoogle Scholar
  • 20 Ekselius L, Knorring L von. Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care.  J Clin Psychopharmacol. 2001;  21 154-160
    CrossrefPubMedGoogle Scholar
  • 21 Kennedy S H, Eisfeld B S, Dickens S E. et al . Antidepressant-Induced Sexual Dysfunction During Treatment With Moclobemide, Paroxetine, Sertraline, and Venlafaxine.  J Clin Psychiatry. 2000;  61 276-281
    CrossrefPubMedGoogle Scholar
  • 22 Montejo-Gonzalez A L, Llorca G, Izquierdo J A. et al . SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.  J Sex Marital Ther. 1997;  23 176-194
    CrossrefPubMedGoogle Scholar
  • 23 Philipp M, Tiller J W, Baier D. et al . Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.  Eur Neuropsychopharmacol. 2000;  10 305-314
    PubMedGoogle Scholar
  • 24 Fink H A, MacDonald R, Rutks I R. et al . Trazodone for erectile dysfunction: a systematic review and meta-analysis.  BJU Int. 2003;  92 441-446
    CrossrefPubMedGoogle Scholar
  • 25 Nurnberg H G, Seidman S N, Gelenberg A J. et al . Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression.  Urology. 2002;  60 58-66
    CrossrefPubMedGoogle Scholar
  • 26 Goldstein I, Lue T F, Padma-Nathan H. et al . Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.  N Engl J Med. 1998;  338 1397-1404
    CrossrefPubMedGoogle Scholar
  • 27 Seidman S N, Roose S P, Menza M A. et al . Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate.  Am J Psychiatry. 2001;  158 1623-1630
    CrossrefPubMedGoogle Scholar
  • 28 Muller M J, Benkert O. Lower self-reported depression in patients with erectile dysfunction after treatment with sildenafil.  J Affect Disord. 2001;  66 255-261
    CrossrefPubMedGoogle Scholar
  • 29 Tignol J, Furlan P M, Gomez-Beneyto M. et al . Efficacy of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in remission from depression.  Int Clin Psychopharmacol. 2004;  19 191-199
    PubMedGoogle Scholar
  • 30 Milman H A, Arnold S B. Neurologic, psychological, and aggressive disturbances with sildenafil.  Ann Pharmacother. 2002;  36 1129-1134
    CrossrefPubMedGoogle Scholar
  • 31 Schultheiss D, Muller S V, Nager W. et al . Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials.  World J Urol. 2001;  19 46-50
    PubMedGoogle Scholar
  • 32 Grass H, Klotz T, Fathian-Sabet B. et al . Sildenafil (Viagra): is there an influence on psychological performance?.  Int Urol Nephrol. 2001;  32 409-412
    CrossrefPubMedGoogle Scholar
  • 33 Arnavaz A, Aurich A, Weissenborn K. et al . Effect of sildenafil (Viagra) on cerebral blood flow velocity: a pilot study.  Psychiatry Res. 2003;  122 207-209
    PubMedGoogle Scholar
  • 34 Kruuse C, Thomsen L L, Jacobsen T B. et al . The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects.  J Cereb Blood Flow Metab. 2002;  22 1124-1131
    PubMedGoogle Scholar
  • 35 Morales A, Gingell C, Collins M. et al . Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction.  Int J Impot Res. 1998;  10 69-73
    CrossrefPubMedGoogle Scholar
  • 36 Labbate L A, Croft H A, Oleshansky M A. Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation.  J Clin Psychiatry. 2003;  64 (Suppl 10) 11-19
    PubMedGoogle Scholar
  • 37 Montejo A L, Llorca G, Izquierdo J A. et al . Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.  J Clin Psychiatry. 2001;  62 (Suppl 3) 10-21
    Google Scholar
  • 38 Fava M, Rankin M. Sexual functioning and SSRIs.  J Clin Psychiatry. 2002;  63 (Suppl 5) 13-16
    PubMedGoogle Scholar
  • 39 Kang B J, Lee S J, Kim M D. et al . A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction.  Hum Psychopharmacol. 2002;  17 279-284
    PubMedGoogle Scholar
  • 40 Nelson E B, Shah V N, Welge J A. et al . A placebo-controlled, crossover trial of granisetron in SRI-induced sexual dysfunction.  J Clin Psychiatry. 2001;  62 469-473
    PubMedGoogle Scholar
  • 41 Masand P S, Ashton A K, Gupta S. et al . Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study.  Am J Psychiatry. 2001;  158 805-807
    CrossrefPubMedGoogle Scholar
  • 42 Nurnberg H G, Gelenberg A, Hargreave T B. et al . Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors.  Am J Psychiatry. 2001;  158 1926-1928
    CrossrefPubMedGoogle Scholar
  • 43 Nurnberg H G, Hensley P L, Gelenberg A J. et al . Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial.  JAMA. 2003;  289 56-64
    CrossrefPubMedGoogle Scholar
  • 44 Nurnberg H G, Duttagupta S. Economic analysis of sildenafil citrate (Viagra) add-on to treat erectile dysfunction associated with selective serotonin reuptake inhibitor use.  Am J Ther. 2004;  11 9-12
    PubMedGoogle Scholar

Dr. med. Sebastian Walther

Universitäre Psychiatrische Dienste Bern · Direktion Sozial- und Gemeindepsychiatrie

Bolligenstrasse 111

3000 Bern 60

Schweiz

eMail: Sebastian.Walther@gef.be.ch

      >